OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Prothena Corporation PLC/  IE00B91XRN20  /

NASDAQ
2024-12-20  10:00:00 PM Chg. -0.7900 Volume Bid1:02:36 AM Ask1:02:36 AM Market Capitalization Dividend Y. P/E Ratio
15.2200USD -4.93% 1.56 mill.
Turnover: 18.54 mill.		 14.7200Bid Size: 1,000 16.3400Ask Size: 800 607.51 mill.USD 0.00% -
GlobeNewswire 08-05 ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice Presid...
GlobeNewswire 2022-03-28 Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under ...
GlobeNewswire 2022-03-21 Prothena to Participate in Stifel 2022 Virtual CNS Days
GlobeNewswire 2022-03-16 Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
GlobeNewswire 2022-02-17 Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidanc...
GlobeNewswire 2022-02-10 Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference C...
GlobeNewswire 2021-11-29 Prothena to Participate in JMP Securities Hematology and Oncology Summit
GlobeNewswire 2021-11-04 Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 2021-10-28 Prothena to Report Third Quarter 2021 Financial Results on November 4th
GlobeNewswire 2021-10-01 Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2021-10-01 Prothena Announces Executive Appointments
GlobeNewswire 2021-09-03 Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2021-09-01 Prothena to Participate in Upcoming September Healthcare Conferences
GlobeNewswire 2021-08-05 Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 2021-07-29 Prothena to Report Second Quarter 2021 Financial Results on August 5th
GlobeNewswire 2021-07-26 Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association Internat...
GlobeNewswire 2021-07-20 Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association...
TeleTrader 2021-07-12 Novo Nordisk buys Prothena's heart therapy drug
GlobeNewswire 2021-07-12 Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
GlobeNewswire 2021-06-24 Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global N...
GlobeNewswire 2021-06-10 Prothena to Participate in JMP Securities Life Sciences Conference on June 16
GlobeNewswire 2021-05-20 Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors
GlobeNewswire 2021-05-11 Prothena Reports First Quarter 2021 Financial Results and Provides Updated Financial Guidance and R&...
GlobeNewswire 2021-05-10 Prothena Announces Achievement of $60 Million Milestone From Roche for First Patient Dosed in Phase ...
GlobeNewswire 2021-05-07 Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)